Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001478

Drug Information
NameFenfluramine    
SynonymsPonderax (TN); MolPort-001-794-054; 2-Ethylamino-1-(3-trifluoromethylphenyl)propane; DEA No. 1670; Pesos; (+/-)-Fenfluramine hydrochloride; Adipomin; AC-16024; LS-103506; DB00574; Dextrofenfluramine; fenfluramine; NCGC00159473-03; Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-, (+-)-; 3-(Trifluoromethyl)-N-ethyl-alpha-methylphenethylamine; Fenfluramine, (+-)-Isomer; Prestwick_868; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)- (9CI); Obedrex; 1-(meta-Trifluoromethyl-phenyl)-2 ethylaminopropane; Phenethylamine, N-ethyl-.alpha.-methyl-m-(trifluoromethyl)-; LS-103505; Dexfenfluramina [Spanish]; DivK1c_000980; Adifax; S 768; (+-)-Fenfluramine; NINDS_000980; NCGC00159473-04; Dexfenfluraminum; 458-24-2; HSDB 7356; CID3337; LS-103507; EINECS 207-276-3; N-Ethyl-alpha-methyl-3-trifluoromethylphenethylamine; Dexfenfluraminum [Latin]; 404-82-0 (hydrochloride); 1-(m-trifluoromethyl-phenyl)-2-ethylaminopropane; N-Ethyl-alpha-methyl-3-(trifluoromethyl)benzeneethanamine; L000742; UNII-2DS058H2CF; d-Fenfluramine; (S)-Fenfluramine; Fenfluraminum; HSDB 3080; NCGC00159473-02; AC1Q31F0; IDI1_000980; Ponderex; Fenfluramina [DCIT]; Rotondin; N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine; (+)-Fenfluramine; Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-; Fenfluramina; Fenfluramine (INN); d-N-Ethyl-alpha-methyl-m-trifluoromethylphenethylamine; Phenethylamine, N-ethyl-alpha-methyl-m-(trifluoromethyl)-, (S)-; C12H16F3N; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-; DB01191; 5220-89-3; Isomeride; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)-; BRN 4783711; N-Ethyl-alpha-methyl-m-(trifluoromethyl)phenethylamine; D07945; AC1L1FPE; Levofenfluramine [INN]; Dexafenfluramine; Fenfluramine [INN:BAN]; Ponderax PA; Acino; Benzeneethanamine, N-ethyl-.alpha.-methyl-3-(trifluoromethyl)-; AC1Q31EZ; ()-Fenfluramine hydrochloride; Dexfenfluramina; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (+-)-; Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)- (9CI); Benzeneethanamine, N-ethyl-alpha-methyl-3-(trifluoromethyl)-, (S)- (9CI); Fenfluraminum [INN-Latin]; Dexfenfluramine [INN:BAN]; Dexfenfluramine; 3239-44-9; KBio1_000980; C06996; CHEBI:5000; CHEMBL87493    
IndicationObesityApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
CAS NumberCAS 458-24-2
PubChem Compound IDCID 3337.    
PubChem Substance IDSID 9209.    
SuperDrug ATC IDA08AA02;    
SuperDrug CAS ID000458242;    
Target5-HT receptorAntagonist[2]
Ref 1Obesity: pathophysiology and clinical management. Curr Med Chem. 2009;16(4):506-21. To Reference
Ref 2Pharmacotherapy for obesity. Drugs. 2005;65(10):1391-418. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543